Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Cabaletta Bio

Cabaletta Bio

Cabaletta Bio is a biotechnology company developing cellular therapies for autoimmune disease.

OverviewStructured DataIssuesContributorsActivity
Is a
Company
Company
Organization
Organization
CEO
Steven Nichtberger
Steven Nichtberger
CFO
Anup Marda
Anup Marda
Legal Name
Cabaletta Bio, Inc.
Company Operating Status
Active
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...etta-bio
Date Incorporated
2017
Email Address
contactus@cabalettabio.com
Founded Date
2017
Founder
Steven Nichtberger
Steven Nichtberger
Full Address
2929 Arch Street, Suite 600 Philadelphia, PA, 19104, US
Industry
‌
CAR T-Cell therapy
Stem cell
Stem cell
Healthcare
Healthcare
Immunotherapy
Immunotherapy
Cell therapy
Cell therapy
Autoimmune disease
Autoimmune disease
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Biotechnology
Biotechnology
‌
Allogeneic cell therapy
•••
Investors
Deerfield Management
Deerfield Management
5AM Ventures
5AM Ventures
Adage Capital Management
Adage Capital Management
Redmile Group
Redmile Group
Cormorant Capital
Cormorant Capital
Boxer Capital
Boxer Capital
Latest Funding Round Date
January 2019
Latest Funding Type
Series B Round
Series B Round
LinkedIn URL
@company/cabalettabio/about
Location
United States
United States
Philadelphia
Philadelphia
Pennsylvania
Pennsylvania
Number of Employees (Ranges)
51 – 200
Phone Number
+1 267 759 3100
Pitchbook URL
pitchbook.com/profiles...234478-54
Exchange
Nasdaq
Nasdaq
Stock Symbol
CABA
Ticker Symbol
CABA
Total Funding Amount (USD)
50,000,000
Twitter URL
@CabalettaBio
Official Website
cabalettabio.com
cabalettabio.com

Find more companies like Cabaletta Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.